Effects of epidermal growth factor receptor‐tyrosine kinase inhibitors alone on EGFR‐mutant non‐small cell lung cancer with brain metastasis

BACKGROUND: Epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs) are remarkably effective for treating EGFR‐mutant non‐small cell lung cancer (NSCLC). However, the individual role of EGFR‐TKIs in patients with brain metastasis (BM) arising from EGFR‐mutant NSCLC remains unclear. M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thorac Cancer
Main Authors: Zhang, Qiuyi, Zhang, Xuchao, Yan, Honghong, Jiang, Benyuan, Xu, Chongrui, Yang, Jinji, Chen, Zhihong, Su, Jian, Wu, Yi‐Long, Zhou, Qing
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons Australia, Ltd 2016
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5093172/
https://ncbi.nlm.nih.gov/pubmed/27755835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12379
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados